Ralf Dechend Selected Research

Type 2 Diabetes Mellitus (MODY)

1/2021	Intrauterine Exposure to Diabetic Milieu Does Not Induce Diabetes and Obesity in Male Adulthood in a Novel Rat Model.
1/2018	Diabetes Mellitus in Pregnancy Leads to Growth Restriction and Epigenetic Modification of the Srebf2 Gene in Rat Fetuses.
10/2016	Benefits and Risks of Aliskiren Treatment in Patients With Type 2 Diabetes: Analyses of the 3A Registry.
1/2016	Two-Year Outcomes of Patients Treated With Aliskiren Under Clinical Practice Conditions: Non-Interventional Prospective Study.
10/2012	Cardiovascular risk markers in pregnancies complicated by diabetes mellitus or preeclampsia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ralf Dechend Research Topics

Disease

84	Pre-Eclampsia (Preeclampsia) 01/2024 - 04/2003
65	Hypertension (High Blood Pressure) 09/2023 - 12/2002
18	Inflammation (Inflammations) 01/2023 - 01/2002
17	Albuminuria 04/2021 - 01/2002
14	Fibrosis (Cirrhosis) 01/2023 - 11/2002
13	Ischemia 01/2023 - 09/2002
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2008
8	Heart Failure 01/2023 - 02/2005
8	Cardiomegaly (Heart Hypertrophy) 01/2020 - 01/2005
7	Proteinuria 12/2019 - 06/2008
6	Autoimmune Diseases (Autoimmune Disease) 05/2023 - 04/2011
6	Body Weight (Weight, Body) 12/2021 - 11/2007
6	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2020 - 08/2010
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2012
4	Hypoxia (Hypoxemia) 01/2019 - 07/2009
4	Diabetes Mellitus 01/2018 - 07/2009
3	Atherosclerosis 12/2023 - 07/2003
3	Neoplasms (Cancer) 05/2023 - 03/2008
3	Infections 05/2023 - 07/2003
3	Thrombosis (Thrombus) 12/2019 - 07/2007
3	Alzheimer Disease (Alzheimer's Disease) 12/2018 - 11/2013
3	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2018 - 10/2012
3	Necrosis 11/2015 - 09/2002
3	Atrial Remodeling 11/2014 - 08/2007
3	Vascular System Injuries 12/2012 - 02/2002
2	Systemic Scleroderma (Systemic Sclerosis) 05/2023 - 12/2018
2	Insulin Resistance 01/2022 - 03/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 07/2011
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2021 - 07/2011
2	Stroke (Strokes) 01/2021 - 01/2018
2	Birth Weight (Birth Weights) 04/2020 - 01/2019
2	Hypertrophy 01/2020 - 02/2005
2	Bradycardia 01/2020 - 09/2008
2	Ovarian Neoplasms (Ovarian Cancer) 12/2018 - 01/2016
2	Ovarian Epithelial Carcinoma 06/2018 - 01/2016
2	Glucose Intolerance 01/2018 - 03/2009
2	Edema (Dropsy) 11/2015 - 02/2010
2	Hemolysis 02/2015 - 05/2013
2	HELLP Syndrome 02/2015 - 05/2013
2	Obesity 07/2011 - 03/2009

Drug/Important Bio-Agent (IBA)

38	AutoantibodiesIBA 12/2023 - 11/2004
36	Angiotensin IIIBA 01/2023 - 01/2002
15	ReninIBA 01/2020 - 02/2005
13	AntibodiesIBA 01/2022 - 11/2004
13	AngiotensinsIBA 01/2021 - 02/2002
12	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2009
12	Type 1 Angiotensin ReceptorIBA 01/2023 - 03/2007
10	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2023 - 09/2004
10	AngiotensinogenIBA 01/2021 - 02/2005
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2005
8	SaltsIBA 09/2023 - 01/2005
8	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 01/2012
8	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 07/2003
8	aliskiren FDA Link 10/2016 - 09/2005
7	Endothelin-1 (Endothelin 1)IBA 01/2022 - 10/2009
7	NF-kappa B (NF-kB)IBA 01/2020 - 01/2002
7	Proteins (Proteins, Gene)FDA Link 05/2017 - 07/2003
7	CytokinesIBA 08/2014 - 12/2008
6	Vitamin D FDA LinkGeneric 01/2017 - 04/2013
5	Phosphotransferases (Kinase)IBA 04/2020 - 07/2011
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 03/2002
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2023 - 12/2018
4	C-Reactive ProteinIBA 01/2023 - 09/2005
4	Insulin (Novolin)FDA Link 01/2022 - 10/2015
4	SodiumIBA 01/2022 - 03/2014
4	Messenger RNA (mRNA)IBA 05/2017 - 12/2002
4	Interleukin-6 (Interleukin 6)IBA 12/2016 - 03/2007
4	Atrial Natriuretic Factor (ANF)IBA 04/2013 - 09/2005
4	Losartan (Cozaar)FDA LinkGeneric 05/2012 - 02/2005
4	Thromboplastin (Tissue Factor)IBA 02/2006 - 12/2002
3	Immunoglobulin G (IgG)IBA 01/2023 - 02/2005
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 08/2012
3	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 07/2009
3	Connective Tissue Growth FactorIBA 04/2021 - 03/2007
3	LeptinIBA 01/2021 - 06/2009
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 04/2013
3	Insulin ReceptorIBA 01/2021 - 01/2017
3	Prorenin ReceptorIBA 01/2020 - 01/2016
3	GTP-Binding Proteins (G-Protein)IBA 03/2014 - 03/2013
3	Transcription Factors (Transcription Factor)IBA 11/2007 - 02/2002
2	Troponin IIBA 01/2024 - 10/2020
2	Monoclonal AntibodiesIBA 05/2023 - 11/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
2	AlbuminsIBA 12/2021 - 01/2020
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2020 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2019 - 11/2002
2	Doxycycline (Periostat)FDA LinkGeneric 01/2018 - 08/2010
2	Interleukin-10 (Interleukin 10)IBA 11/2017 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 03/2007
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2017 - 08/2010
2	Retinaldehyde (Retinal)IBA 01/2017 - 01/2016
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2016 - 02/2015
2	RelaxinIBA 01/2016 - 01/2014
2	AntioxidantsIBA 10/2015 - 10/2004
2	EnzymesIBA 02/2015 - 05/2013
2	salicylhydroxamic acid (SHAM)IBA 02/2015 - 09/2002
2	Peptides (Polypeptides)IBA 11/2013 - 12/2012
2	AdipokinesIBA 07/2011 - 06/2009

Therapy/Procedure

4	Therapeutics 05/2023 - 10/2016
2	Cesarean Section (Caesarean Section) 01/2018 - 01/2018